Randi Hagerman
Medical Director
MIND Institute
From this contributor
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Researcher Randi Hagerman is a big proponent of metformin — a diabetes drug that she is testing in people with fragile X syndrome. In fact, Hagerman takes the drug herself as a preventive measure against cancer.
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Drug trials for fragile X syndrome lead the way for autism
Several targeted trials on drugs that treat fragile X syndrome are under way. But accurate endpoints to measure the drugs’ effectiveness are crucial, argues developmental and behavioral pediatrician Randi Hagerman.
Drug trials for fragile X syndrome lead the way for autism
Explore more from The Transmitter
Language development during the first 1,000 days; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 9 November.
Language development during the first 1,000 days; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 9 November.
What ‘Brain Flows’ gets right
Michael W. Cole’s new book makes a convincing case that the dynamic movement of signals underpins just about everything the brain does, though it misses mention of relevant theoretical and single-cell work.
What ‘Brain Flows’ gets right
Michael W. Cole’s new book makes a convincing case that the dynamic movement of signals underpins just about everything the brain does, though it misses mention of relevant theoretical and single-cell work.
Amid funding uncertainty, graduate neuroscience programs in the U.S. adapt
The Transmitter surveyed 50 graduate program directors to learn how they’re faring. Securing labs for new students is one of the greatest concerns.
Amid funding uncertainty, graduate neuroscience programs in the U.S. adapt
The Transmitter surveyed 50 graduate program directors to learn how they’re faring. Securing labs for new students is one of the greatest concerns.